Products supplied by ReSyn Biosciences (Pty) Ltd are for research purposes only. ReSyn products are not to be used for diagnostic, therapeutic or commercial purposes. Commercial means any use resulting in monetary gain, including, but not limited to, incorporation in a kit, repackaging and re-formulation. Please enquire about sub-licenses for commercial use.
Home Products Custom services Distributors Literature Contact News
© ReSyn Biosciences (Pty) Ltd 2012-2019
ReSyn Biosciences' Justin Jordaan, PhD, CEO, CSO and Founder (center), Dr. Isak Gerber, CTO, with members of the New Product Award adjudication panel for the MagReSyn® product range.
ReSyn Biosciences will be exhibiting at ASMS 2019  ReSyn Biosciences will be exhibiting at ASMS 2019 from 2-6 June, Atlanta, USA. Please visit us at our booth to learn more about our technology offerings or to discuss your research requirements. ReSyn Biosciences is taking part in the MS-Pillar Phosphopeptide Challenge ReSyn Biosciences has partnered with HUPO and Synpeptide Co. Ltd. for the exciting MS-Pillar Phosphopeptide challenge! HUPO members can join the challenge to achieve the highest possible sequence coverage of a standard phosphopeptide mixture using multiple purification schemes, analytical protocols and data processing strategies. Read more HERE  New product launch at ASMS 2017, Indianapolis: MagReSyn® HILIC MagReSyn® HILIC provides a highly reproducible, unbiased and fully automatable solution for parallel protein sample clean-up prior to MS analysis. Please refer to our product page:  MagReSyn® HILIC for product information and application notes ReSyn Biosciences is a consortium member of the BioCapture Network BioCapture is a European Training Network (ETN) funded by the European Commission under the Horizon 2020 Marie Skłodowska-Curie Action. The network consists of 15 research groups, spread across 11 universities and institutes and 4 industrial partners in 6 different countries that have come together to train a new generation of chemists/phycisists/biologists through an EU-wide PhD training network. The main aim of this interdisciplinary project is to discover new and improved ways to diagnose and treat cancer. Read more at New product launch: MagReSyn® Trypsin and Chymotrypsin ReSyn has recently launched new high content, magnetically immobilized, trypsin and chymotrypsin for rapid, automated digestion of proteins for mass spectrometry sample preparation. Multipoint covalent attachment of the enzymes results in improved enzyme stability, resulting in retention of activity under denaturing sample conditions, e.g. urea and SDS (trypsin). The microparticles are best suited for automated digestion on magnetic handling stations, reducing variability in sample preparation, thereby improving reproducibility. For more information, please visit the MagReSyn® Trypsin and MagReSyn® Chymotrypsin  Product Pages ReSyn Biosciences wins New Product Award at SLAS 2015, Washington DC, USA ReSyn Biosciences was awarded a prestigious New Product Award (NPA) at the Society for Lab Automation and Screening (SLAS) Conference and exhibition in Washington DC, Feb. 7-11, 2015. The designation was awarded for the entire MagReSyn® product range. The NPA designation is bestowed to new products for the potential to impact the fields of automation, screening and drug discovery. Of the 296 companies exhibiting, 61 submitted products for consideration of an NPA award, with a total of four awards being conferred at the 2015 event. Other companies receiving an award for their innovative products were Sony Corporation, regenHU, and BlueCatBio. Read the full press release HERE